Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial of imatinib mesylate in locally advanced gastrointestinal stromal tumor has completed. Trial results are not detailed in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib Mesylate (Gleevec) (Imatinib mesylate)

Snippet

Sponsor: Technical University of Munich | Conditions: Gastrointestinal Stromal Tumor | Phase 2 | Status: COMPLETED